KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Capital Expenditures: 2017-2025

Historic Capital Expenditures for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $12.4 million.

  • Twist Bioscience's Capital Expenditures rose 520.73% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year increase of 451.69%. This contributed to the annual value of $28.0 million for FY2025, which is 451.69% up from last year.
  • As of Q3 2025, Twist Bioscience's Capital Expenditures stood at $12.4 million, which was up 35.59% from $9.2 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Capital Expenditures registered a high of $40.6 million during Q2 2022, and its lowest value of $603,000 during Q1 2024.
  • In the last 3 years, Twist Bioscience's Capital Expenditures had a median value of $2.4 million in 2023 and averaged $4.5 million.
  • In the last 5 years, Twist Bioscience's Capital Expenditures crashed by 93.34% in 2024 and then soared by 849.74% in 2025.
  • Twist Bioscience's Capital Expenditures (Quarterly) stood at $12.8 million in 2021, then dropped by 7.50% to $11.8 million in 2022, then tumbled by 87.26% to $1.5 million in 2023, then skyrocketed by 50.60% to $2.3 million in 2024, then soared by 520.73% to $12.4 million in 2025.
  • Its Capital Expenditures stands at $12.4 million for Q3 2025, versus $9.2 million for Q2 2025 and $4.1 million for Q1 2025.